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Abstract
Recent advances in biophysical methods have been able to shed more light on the structures of helical bundles formed by the
transmembrane segments of bitopic membrane proteins. In this manuscript, I attempt to review the biological importance and diversity of
these interactions, the energetics of bundle formation, motifs capable of inducing oligomerization and methods capable of detecting, solving
and predicting the structures of these oligomeric bundles. Finally, the structures of the best characterized instances of transmembrane a-
helical bundles formed by bitopic membrane proteins are described in detail.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
A domain is normally defined as a protein segment
capable of folding independently, that is, an independent
folding unit. As such, a transmembrane a-helix, comprised
of ca. 20 amino acids [1], is not only one of the smallest of
all protein domains, but also the simplest, in which secon-
dary and tertiary structures are one. Any protein that
possesses a single transmembrane a-helix is designated as
a bitopic membrane protein, whereas proteins with more
than one transmembrane a-helix are termed polytopic.
Genomic analyses employing various techniques (e.g.
hydropathy algorithms) predict that 10–20% of all open
reading frames in nearly all of the genomes studies so far,
contain a single putative transmembrane a-helix [2–5].
However, it is important to note that such analyses do not
detect a common feature of many single transmembrane a-
helices: oligomerization. The process of oligomerization
may transform a simple membrane anchor into a biolog-
ically active complex. This review will focus on the struc-
tural aspects of oligomerization taking place between the
transmembrane a-helices of bitopic membrane proteins.
The driving force behind the formation of quaternary
structure (i.e. oligomerization) can be of two, non-exclusive
types:
 Formation of covalent bonds between the protomers,
such as disulfide bonds.
 Non-covalent, specific interactions that take place
between the protomers.
The oligomerization of a bitopic membrane protein that
takes place due to interactions between its transmembrane
a-helix is most likely non-covalent. The reason being, is
that a prerequisite for disulfide bond formation, is the
deprotonation of the thiol group. This charge separation is
highly unlikely in the low dielectric environment of the lipid
bilayer. Thus, it should not be surprising to realize that to the
knowledge of the author, no evidence of native disulfide
bonds has ever been recorded taking place in the membrane
milieu.
In this review, we will only concern ourselves with non-
covalent oligomerization that takes place between bitopic
membrane proteins, through their transmembrane domains.
Thus, for the sake of brevity, in this review, the term
oligomerization will henceforth refer to the following:
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‘‘Non-covalent oligomerization taking place between bitopic
membrane proteins, due to their transmembrane a-helices’’.
It is important to note, however, that the oligomerization
between polytopic membrane proteins is a very common
phenomenon as well: nearly all helical membrane proteins
whose structures have been solved are oligomeric.
I will begin by providing a brief overview of the bio-
logical importance and prevalence of bitopic transmembrane
helix oligomerization, followed by a discussion of the
energetic factors that may govern such interactions. Subse-
quently, methods used to detect non-covalent oligomeriza-
tion events will be mentioned as they are key in identifying
such phenomena before any structural characterization.
Experimental methods capable of solving structures of trans-
membrane helical bundles will be discussed, alongside
computational prediction approaches. The structure of the
best characterized instance of an oligomeric helical bundle
will be discussed in detail: the dimerizing human erythrocyte
sialoglycoprotein, glycophorin A. Finally, two other exten-
sively characterized helical bundles will be described: (i) the
tetramerizing Influenza A M2 H+ channel and (ii) the
pentamerizing human cardiac sarcoplasmic reticulum pro-
tein, phospholamban.
1.1. Biological importance
While many examples of non-covalent oligomerization
events taking place between bitopic membrane proteins, due
to their transmembrane a-helices, are present in the liter-
ature, it is difficult to estimate how prevalent this phenom-
enon is, due to the experimental difficulty in detecting such
events (see Section 1.4). Superficially, therefore, it is pos-
sible to distinguish between two kinds of oligomerization
events: (i) those that we can experimentally detect and (ii)
those that we know exist. Specifically, there are several
examples in which the oligomerization between transmem-
brane helices can be observed experimentally [e.g. by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS-PAGE)]. Conversely, there are examples in which
mutations in what would otherwise be considered a simple
transmembrane anchor, lead to altered functionality of the
protein. In such instances, one may surmise that the trans-
membrane a-helix is undergoing some sort of oligomeriza-
tion event.
On a fundamental level, it is possible to classify all
oligomerization events as belonging to one of the following
two types: (i) homo-oligomers and (ii) hetero-oligomers. So
far in the literature, more examples of homo-oligomers have
been reported than that of hetero-oligomers. It is interesting
to note that due to symmetry considerations (see below),
homo-oligomers prove to be much easier subjects to study
computationally, but are perhaps more difficult to study
experimentally by techniques such as nuclear magnetic
resonance (NMR) (see Section 2).
Below I briefly describe two representative examples of
bitopic membrane protein families that oligomerize due to
their transmembrane domains. The examples described do
not imply any particular prevalence or prominent impor-
tance on the part of those families that were listed. I merely
wish to provide key examples emphasizing the biological
diversity and importance of these interactions.
1.1.1. Symmetry in homo-oligomers
Homo-oligomerization between transmembrane a-heli-
ces has been detected in many instances. Three prime
examples are glycophorin A, phospholamban and Influenza
A M2 H+ channel, the structures of which will be described
in detail in Section 2. One important consideration in
analyzing the structure of such complexes is the assumption
of symmetry. Symmetry results in obvious simplifications in
computational analyses and as such, is a compelling
restraint to employ. The general justification and validity
of the symmetry assumption in homo-oligomeric bundles is
based on two lines of evidence:
 Nearly all homo-oligomeric protein structures (mem-
brane or water soluble) found in the protein data bank
exhibit symmetry. Exceptions are rare and normally
result from the binding of a ligand or substrate to only
one of the monomers, thereby breaking the system
symmetry (e.g. hexokinase [6]).
 Energetic considerations that govern the interactions
between identical subunits favor a symmetric arrange-
ment. The rationale being is that every non-symmetric
arrangement can exist in more than one energetically
equivalent configuration, leading to interconversion and
system instability (see Fig. 1).
1.1.2. Receptor tyrosine kinases
Receptor tyrosine kinases (RTK) comprise an important
class of cell surface receptors (see Refs. [7,8] for review).
The archetypical RTK (e.g. epidermal growth factor recep-
tor) is a bitopic membrane protein with an extracellular
hormone binding domain, a single transmembrane a-helix
and an intracellular region containing a tyrosine kinase
domain. In general, activation of the receptor is thought to
take place through ligand-induced dimerization of the
receptor, leading to cross (auto) phosphorylation of the
intracellular tyrosine kinase domains.
The role of the transmembrane a-helices in the dimeriza-
tion process has so far been perceived as passive. Recently,
however, several lines of evidence have provided data imply-
ing that the transmembrane domains may wield some of the
dimerization potential for the interactions through the for-
mation of ligand independent pre-dimerization. This ten-
dency of the transmembrane domains of RTKs may explain
several findings that were difficult to explain based on
dimerization due solely to extracellular hormone binding:
 There is a growing body of evidence to support the
notion that the transmembrane domains of several RTKs
have the ability to dimerize (e.g. the erbB family of
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receptor [9–11]). Furthermore, the transmembrane do-
mains of cytokine receptors (not true RTKs) such as the
erythropoietin receptor have been shown to have similar
tendencies [12,13]. Thus, ligand binding does not induce
dimerization in these instances, but presumably results in
changing the conformation of the pre-dimerized receptor
structure. That ligand-induced conformational change
(but not induced dimerization) is possible, and is known
from several RTKs (e.g. insulin receptor [8]) that are
known to be covalently bound dimers irrespective of
hormone presence.
 An oncogenic mutation (ValZ Glu) was identified in the
transmembrane domain of the new (ErbB2) oncogene
[14,15]. Furthermore, biophysical studies employing
solid-state NMR spectroscopy were able to show that
in a peptide encompassing the transmembrane domain of
neu, hydrogen bonding was observed between the two
glutamate protonated carboxylates [16].
 An oncogenic retrovirus contains a truncated human
protein, ErbB, in which the entire extracellular domain is
missing, yet is fully and constitutively active (see Refs.
[9,10] for reviews). In this instance, dimerization of the
receptor cannot be driven by the missing extracellular
hormone binding domain.
1.1.3. Viral ion channels
As an initial step toward understanding the molecular
biology that underlies the pathogenic activity of a virus, the
entire viral genome is often sequenced. The research com-
munity will subsequently tend to focus on unique viral
proteins, such as the spike proteins, nucleic acid poly-
merases and proteases. However, the genomes of many
viruses may often contain in addition small hydrophobic
(SH) proteins, including: 3A from Poliovirus [17], 6K from
Semliki Forest virus [18], SH from Simian virus 5 [19], SH
from Respiratory Syncytial Pneumovirus [20], M2 from
Influenza A [21], NB from Influenza B [22], CM2 from
Influenza C [23] and vpu from HIV [24].
M2, the archetypical small hydrophobic viral protein (see
Section 2.2), is by far the best characterized member of the
family and exhibits properties that are thought to be repre-
sentative:
 A small (100>) bitopic membrane protein.
 Non-covalent homo-oligomerization driven by the trans-
membrane a-helical domain. In some instances, the
oligomer may be additionally stabilized by disulfide
bonds between residues in the extramembranous regions
of the protein.
 Ion channel activity that is entirely due to the trans-
membrane a-helical bundle.
Both the existence of anti-Influenza agents targeting and
blocking the M2 channel, and the fact that classical ion
channels have long been used as highly successful targets
for point intervention by pharmaceutical agents, suggest that
the SH viral protein family may represent a new and
important target for viral therapy that has so far received
little attention.
1.2. Energetic considerations
It is instructive to compare the features of water-soluble
helical bundles with those of membrane helical bundles in
terms of their stabilization energies. Both membrane and
water-soluble helical bundles are proteins of similar fold, yet
they exist in dramatically different environments. Compa-
rative analysis of the packing interactions of water-soluble
and membrane helical bundles by Eilers et al. [25] indicated
that while the overall topology of both families of protein is
similar, the packing density of membrane helical bundles is
Fig. 1. Schematic representation of symmetric (right) and asymmetric (center and left) arrangements of a homo-oligomeric dimer. For clarity, each monomer is
colored differently, although in reality, they are indistinguishable. Note that the two different kinds of asymmetric arrangements are energetically equivalent.
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significantly higher. This results from the large number of
small residues (e.g. Gly) in the protein–protein interface,
enabling close apposition of the helices [26].
Interestingly, recent studies by Frank et al. [27] and later
on by Li et al. [28] have shown that a transmembrane helical
bundle (phospholamban, see Section 2.3) can be converted
into a water-soluble bundle by substituting apolar residues
in the exterior of the protein to polar residues. Furthermore,
Frank et al. were able to show that the resulting water-
soluble bundle retained the same contact-specific interface
[27]. Thus, the forces that govern the interactions inside the
membrane may be of similar nature to those of water-
soluble proteins.
Finally, one other component to take into consideration
is the contribution of the lipids to the stabilization of the
helical bundle. The reason being is that any oligomerization
event results in a reduced number of helix–lipid interac-
tions and increases the number of lipid–lipid interactions.
There are several examples in the literature in which
specific lipids are needed to maintain the protein structure
and function (see Ref. [29] for review). However, more
often than not, membrane proteins retain both their function
and structure when moved from one lipid system to the
other, or even into detergent micelles (albeit with a possible
reduction in stability [30]). When the above is true, it is
difficult to assume that lipids play a substantial role in the
specific interactions taking place between transmembrane
a-helices.
1.2.1. Water-soluble helical bundles
The energetic basis for the oligomerization of water-
soluble a-helices (e.g. leucine zippers) has been character-
ized extensively [31]. In brief, the driving force for oligome-
rization is thought to derive mainly from the sequestration of
hydrophobic residues from the aqueous environment. Addi-
tional contributions to the interaction specificity (at the
possible expense of stability) are thought to arise from polar
interactions such as H bonding [32].
1.2.2. Transmembrane helical bundles
Our understanding of the energetic basis of transmem-
brane a-helical bundle formation lags considerably behind
that of water-soluble bundles, mostly due to experimental
difficulties. The most fundamental measurement that is
needed when studying oligomerization is missing: an oli-
gomerization detection assay that takes place in the natural
environment of the protein: the lipid bilayer (see Section
1.4). It is for this reason that theoretical considerations have
in many cases advanced more rapidly than the gathering of
basic thermodynamic data to substantiate such theories.
Nonetheless, several theoretical considerations have proven
very useful.
The two-stage model [33,34] for membrane protein
folding and oligomerization has been particularly useful in
forming a conceptual framework in which to analyze
membrane protein oligomerization. The model states that
membrane proteins oligomerize (or in the case of polytopic
membrane proteins, fold) in two stages:
1. Formation of independently stable transmembrane a-
helices.
2. Association of the independently stable transmembrane
helices to form an a-helical bundle.
In conclusion, the two-stage model maintains that before
oligomerization, the a-helices are independently stable. This
fundamental assumption precludes any bitopic membrane
protein from having a transmembrane a-helix that is sub-
stantially amphiphatic. This is indeed consistent with
sequence analysis that identified a larger proportion of polar
residues in polytopic putative membrane proteins versus
bitopic proteins [35]. Based on the above considerations, it
is unlikely that the driving forces behind the oligomerization
of transmembrane a-helices is simply the reverse of that
found in water-soluble helices: the sequestration of polar
residues from the apolar environment [36]. Therefore, to
understand the forces that bring together mostly apolar
helices in a membrane environment, one should look at
other interactions in addition to the formation of salt-bridges
and inter-helix hydrogen bonding. Below I describe the
most rigorous analysis of the energetics of transmembrane
a-helix association, undertaken for human glycophorin A.
1.2.3. The energetics of glycophorin A dimerization
Glycophorin A was the first membrane protein whose
sequence was determined, identifying in the process a long
stretch of hydrophobic amino acids [37]. Furthermore,
glycophorin A provided the first clear example of a bitopic
membrane protein oligomerizing (more specifically, dime-
rizing) non-covalently due to specific interactions of its
transmembrane a-helices (see Ref. [38] for review). As an
example, the transmembrane domain of glycophorin A
could be fused to a monomeric, water-soluble protein,
resulting in the dimerization of the resulting chimera [39].
The dimerizing transmembrane a-helices of human
erythrocyte sialoglycoprotein, glycophorin A, were exten-
sively analyzed by saturation mutagenesis [40] and Ala
insertions [41,42], assaying their ability to dimerize in
SDS micelles by electrophoresis (i.e. non-equilibrium con-
ditions). The sensitivity of some of the residues toward
disruption was remarkably exquisite, whereby in some
instances the addition or removal of a single methyl group
was sufficient to prevent dimerization [40]. It was later on
demonstrated [43] that the residues found to be sensitive
toward substitution constituted the first known dimerization
motif for transmembrane a-helices, as expanded in Section
1.3.
MacKenzie and Engelman [44] reported an insightful
analysis relating the effects of each of the mutations to the
nature of the substituted amino acid. Five empirical param-
eters were attributed to each substitution: (i) side-chain
rotamer entropy change, (ii) increase of favorable van der
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Waals contacts, (iii) introduction of steric clashes, (iv)
hydrophobicity using the GES scale [45] and (v) side-chain
volume. In their multivariant regression analysis of apolar
substitutions, MacKenzie and Engelman [44] were able to
show that the contributions toward dimerization were as
follows:
 Side-chain rotamer entropy: The energetic contribution
to dimer formation due to the change of side-chain
entropy was found to be significant.
 van der Waals contacts: The formation of favorable van
der Waals contacts was found to be essential to
dimerization, as expected.
 Steric clashes: The introduction of steric clashes was
drastically detrimental to dimer formation. Its magnitude
indicated that its value superseded any other contribution.
 Hydrophobicity and volume: The hydrophobicity or
volume of the particular side chain was found to be a
very poor predictor of dimer stability, amongst the subset
of apolar amino acids used in the study. The effect of
strongly polar substitutions is thought to occur in stage I
of the folding of the protein, through the decrease of the
stability of the helix protomer (see Section 1.2.2 and Ref.
[39]).
1.2.4. Contribution of polar interactions to oligomerization
energetics
Recently, Fang-Xiao et al. [47] and Choma et al. [48]
were able to demonstrate the possible importance of polar
interactions toward the stability of an oligomeric complex.
Both groups converted the water-soluble Leucine zipper into
a hydrophobic transmembrane a-helix. Only upon the in-
troduction of the polar amide group of Asn did the helices
oligomerize, non-specifically. The authors thus indicated
that groups capable of H bonding in the bilayer may provide
opportunities for oligomerization stability at the expense of
specificity [47,48].
In a more general study, Gratkowski et al. [49] and later
on Fang-Xiao et al. [50] have investigated the effects of
inserting a variety of polar residues in a background of a
polyleucine transmembrane a-helix. The authors found that
incorporation of a single Asn, Asp, Gln, Glu or His was
capable of inducing homo- or hetero-oligomerization. On
the other hand, the incorporation of Ser, Thr or Tyr was not
able to induce oligomerization. The authors’ rationale of
why the first group was capable of inducing oligomeriza-
tion while the latter was not, was that residues in the first
group are capable of being simultaneous hydrogen-bond
donors and acceptors. The latter group of residues is not
able to.
Senes et al. [51] have more recently shown that the weak
CaUH: : :O hydrogen bond may contribute to the stability
of transmembrane oligomers as well. In this instance, the
close proximity between the juxtaposed helices needed for
such a bond to take place maintains that close packing
interactions precede such bonds forming.
The question then remains as to why strong interactions,
such as (i) disulfide bonds, (ii) intermolecular hydrogen
bonding and (iii) intermolecular salt bridges, are not com-
monly found [52,29]. Both Gratkowski et al. [49] and Fang-
Xiao et al. [50] speculate that such interactions, while
strong, may prove to be promiscuous in the membrane
environment, resulting in non-specific aggregation. Further-
more, such strong interactions may negate any possibility
for regulation of the oligomerization process that might be
essential for function.
1.3. Oligomerization motifs
As stated in Section 1.2.3, it was shown that the residues
found to be sensitive toward substitution in glycophorin A
[40] constituted the first known dimerization motif for
transmembrane a-helices: LIxxGVxxGVxxT [43] (L75-
T87, see red and purple residues in the middle panel of
Fig. 7). Langosch et al. [53] later on showed that when
assayed for dimerization in a lipid bilayer, the motif could
be further minimized to GxxxG (G79–G83, see red residues
in the middle panel of Fig. 7). This finding is consistent with
the fact that the potentially denaturing detergent micelle
environment places more stringent restrictions on the dime-
rization process [30]. Thus, many interactions that are not
observed in SDS-PAGE could still be taking place in a lipid
bilayer and have so far escaped our attention.
Bioinformatics analysis by Arkin and Brunger [1] found
the GxxxG motif to be common in putative transmembrane
a-helices, pointing possibly to the prevalence of this sort of
dimerization. Furthermore, the GxxxG motif was later on
identified by Russ and Engelman [54] when screening
random transmembrane a-helices on the basis of their
ability to oligomerize. Another genetic screen aimed at
identifying oligomerizing transmembrane a-helices was
undertaken by Leeds et al. [55]. In this study, a library of
protein fragments was tested, identifying several successful
candidates. One such candidate was transmembrane helix 6
from the YjiO gene that contained a GxxxA motif [55]
(similar to the GxxxG motif previously identified [43]).
However, in this instance, Ala scanning mutagenesis studies
pointed to the intervening residues as being more sensitive
to substitution.
More recently, Kleiger et al. [56] have identified in the
crystal structure of a water-soluble protein, the E1h subunit
of Pyrobaculum aerophilum pyruvate dehydrogenase, a
GxxxG motif that enables the protein to oligomerize. Thus,
the GxxxG motif may be a general dimerization motif for
transmembrane, as well as water-soluble helices.
Finally, the GxxxG motif is by no means the only oligo-
merization motif preset for transmembrane a-helices, since it
is absent in many known cases of helices that are known to
oligomerize. As an example, Laage et al. [57] were able to
identify entirely different oligomerization motifs for trans-
membrane a-helices based on a heptad of leucine residues,
similar to that found in water-soluble leucine zippers [31].
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1.4. Oligomerization detection
Detecting the oligomerization of transmembrane a-heli-
ces in a lipid bilayer is by no means routine. Furthermore,
even upon detection, accurate assessment of the oligomeric
size (a difficult task on it sown) is needed to interpret the
thermodynamic data. It is for the above reasons that oligo-
merization assays have been developed in membrane mim-
etic conditions.
1.4.1. Oligomerization detection in membranes
As stated above, detecting oligomerization events in
lipid bilayers is difficult. However, several approaches have
been developed aside from the obvious in situ cross-linking
followed by SDS-PAGE. Most notably is the ingenuous
system developed by Langosch et al. [53] based on the
Vibrio cholerae ToxR protein. In this system, transcriptional
activation by ToxR is dependent upon membrane-induced
dimerization [53]. When ToxR is fused to a transmembrane
a-helix and a leader signal, the level of transcriptional
activation will be proportional to oligomerization. Russ
and Engelman [58] have recently utilized the system
invented by Langosch et al. [53] to drive transcription of
an antibiotic resistance gene, enabling genetic selection of
the oligomerization process (this system is called TOX-
CAT).
Leeds et al. [55] have designed an alternative approach for
genetic screening of transmembrane oligomerization based
on the membrane-driven dimerization of the phage E cI
repressor. In this system, dimerization results in maintaining
the phage’s lysogeny.
Additionally, several biophysical methods have been
developed, including fluorescence resonance energy
transfer between fluorescently labeled peptides [59] (see
below).
1.4.2. Oligomerization detection in detergents
There are multiple ways in which oligomerization can be
analyzed in detergents:
 PAGE is a particularly simple, powerful, albeit a non-
equilibrium method that can be used whenever the
protein remains oligomeric in the SDS micelle (e.g.
glycophorin A [40] or phospholamban [60]).
 Analytical ultracentrifugation is a very powerful method
that can be used to gather exact thermodynamic data on
transmembrane helix oligomerization [61].
 Fluorescence resonance energy transfer has been used to
measure helix–helix interaction in detergents [30] as well
as lipid bilayers [59]. While being a very sensitive method
in terms of detection, it suffers greatly from the following
two factors: (i) The need to chemically add two bulky and
potentially artifact causing fluorescent groups to the
peptides. (ii) The estimation of the oligomeric size is not
very accurate leading to difficulties in the thermodynamic
analysis.
 X-ray scattering has recently been shown to be capable of
detecting oligomerization events [62]. However, due to
the complicated nature of the measurements, it remains to
be seen how popular the method will become.
1.5. Structural methods
Structural analysis of membrane proteins has lagged
considerably behind that of water-soluble proteins. Conven-
tional methods aimed at determining protein structure, such
as X-ray crystallography and solution NMR spectroscopy
encounter severe difficulties when analyzing membrane
proteins:
 Crystallization of membrane proteins is notoriously
difficult and as of yet, no X-ray structures of bitopic
helical bundles have been solved.
 High-resolution solution NMR studies are hampered by
the large size of the protein micelle complex. However,
the monumental success of solving the structure of the
glycophorin A transmembrane domain dimer by solution
NMR in detergent micelles [63] (see Section 2) has
indicated that such studies are feasible.
Finally, even upon success, bothmethods studymembrane
proteins not in their native environment, a lipid bilayer, but
rather in detergent micelles.
Two alternative approaches exist that are capable of
studying the structures of isotopically labeled peptides in
lipid bilayers. Both methods derive a list of restraints that
can be used as energy refinement factors in prediction
algorithms (see Section 1.6). While the peptides are studied
in lipid bilayers, the methods are currently limited in terms
of possible candidates to study due to the necessity of
specific isotope incorporation.
 Solid-state NMR methods are capable of yielding both
spatial and distance restraints for membrane peptides (see
Ref. [64] for review). The insensitivity of NMR and
relatively small sample volumes result in peptides
examined at relatively high protein-to-lipid ratios. Fur-
thermore, distance measurements are normally obtained
by magic-angle spinning techniques at low temperatures
(ca.  10 jC).
However, solid-state NMR has so far been able to solve
structures of small integral membrane peptides that were
inaccessible by any of the conventional methods (e.g.
gramicidin [65,66] and M2 [67], see Section 2.2)
 Site-specific Fourier transform infrared (FTIR) spectro-
scopy is a very recent method that is capable of yielding
high-resolution spatial restraints for transmembrane a-
helices [68,69]. The sensitivity of FTIR and large sample
volumes do not impose any limitations on the peptide-to-
lipid ratios used. Furthermore, the experiments can be
undertaken at any temperature desired, and the rapid
nature of the measurements means that multiple con-
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ditions (e.g. lipid nature or the presence of ligand) can
readily be tested. One current limitation of the method is
the need to avoid bulk water over the sample, since water
infrared signals overlap those of the protein. Alternative
vibrational spectroscopy approaches may be able to
alleviate this limitation.
1.6. Prediction methods
Transmembrane helical bundles are relatively simple
structures. Assuming the helices are canonical, a bundle
of n helices can be described by a small set of parameters
(3n), as shown in Fig. 2 [70]. Employing the assumption of
symmetry on homo-oligomeric helical bundles (Section
1.1.1) results in only two global parameters that are needed
to outline the structure. The relative helix tilt b, with
respect to the bundle axis (related to the crossing angle)
and the rotational angle about the helix director /, which
defines which side of the helix is facing toward the bundle
core.
Based on this principle, Treutlein et al. [72] and Adams
et al. [73,74] have developed a systematic algorithm termed
global searching molecular dynamics, capable of searching
this limited configuration space and retrieving possible
solutions. Symmetric bundles are generated by replicating
the helix and rotating it by 360j/n (where n is the oligomer
size). An initial crossing angle of 25j for left-handed and
 25j for right-handed structures is introduced by rotating
the helix with respect to the bundle symmetry axis. A
symmetric search is carried out by applying a rotation to
all helices simultaneously between / = 0j and / = 360j in
given increments (e.g. 10j).
Each of the above starting structures is subjected to
several (e.g. 4) short molecular dynamics runs (each with
a different initial random velocity) aimed at determining the
stability of the starting position. Thus, at the end of the
procedure, the resulting 288 = 36 2 4 structures are
compared, revealing local energy minima to which struc-
tures have clustered to (see Fig. 3). These clusters are then
taken as candidate models, representative of the configu-
ration space that was sampled.
As an example, Fig. 3 depicts the outcome of global
searching molecular dynamics when implemented on gly-
cophorin A, in which more than one cluster is present. How
does one identify the correct structure? Two general
approaches have been used:
 Evaluate each model’s ability to explain external data,
such as mutagenesis studies or evolutionary conservation.
In other words, assume that (i) residues that were found
important by mutagenesis or (ii) those that have been
conserved throughout evolution lie in the protein–protein
interface. This approach has been tried on glycophorin A
with considerable success [40]. When applied to the
pentamerizing phospholamban [60] (see Section 2.3), it
has failed to produce the correct structure [75].
 A more recent approach utilizes evolutionary conserva-
tion and/or mutagenesis data as well, but in an entirely
different way [76]. Rather than concentrating on
conserved residues (either from mutagenesis or evolu-
tion) and make assumptions regarding their function,
make use of silent changes (residues that when changed
have no effect on the structure and function of the
protein). The procedure then calls for applying global
searching molecular dynamics simulations on multiple
sequences, each containing different silent changes.
When the resulting clusters from each of the different
sequences are compared to one another, it is evident that
only one cluster is common throughout all of the
different homologs: the native structure. The rationale
is that only the correct structure must absorb all of the
silent changes. In other words, the silent mutations do not
affect the native structure (by definition) but may not be
compatible with non-native structures. This approach
Fig. 2. In a bundle that contains n helices, 3n parameters are needed to
describe the overall structure, assuming rigid helices: (i) the tilt angle with
respect to the bundle axis, bi, related to the commonly used crossing angle
X [71], (ii) the rotational angle about the helix director, /i, which defines
which side of helix i is facing toward the bundle core and (iii) the helix
register, ri, which defines the relative vertical position of the helix.
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was capable of predicting the structure of glycophorin A
[63] and more recently that of the oligomeric helical
bundle formed by the transmembrane domain of TCR
CD3~ [77,78].
It is also possible to rigorously map the energy surface
of transmembrane helix–helix interactions [70]. In this
procedure, the energy of a helical bundle is calculated
for every possible combination of tilt and rotational pitch
angles at small intervals (ca. 1j). Fig. 4 depicts the result
of such an analysis for the dimerization glycophorin A, in
which a large energy minima is located at a tilt angle of
 23j and a rotational angle of 260j [70]. Remarkably,
these values are virtually identical to those obtained
experimentally by solution NMR [63] (see Section 2).
Note that in the case of a dimer, the inter-helix crossing
angle can be derived directly from the tilt angle of the
helices (X = 2b).
2. Structural examples
2.1. Glycophorin A
Glycophorin A is undoubtedly the best characterized
example of a bitopic membrane protein that oligomerizes
Fig. 3. Energy plots (in polar format) of all the structures obtained from the global search molecular dynamics protocol applied to the glycophorin A homo-
dimer as a function of the helix rotation angle /. The arcs represent each of the individual 288 starting structures in which the arrows designate the direction in
which the starting structure moved during the simulation. The energy of each structure is measured as the distance from the origin. For clarity, the energy of the
starting structure is not illustrated, rather the ‘‘energy’’ of the entire arc is equal to that of the final structure. Each of the structures is colored according to its
cluster affiliation. Left-handed unclustered structures are depicted in black and right-handed unclustered structures in grey. The cluster averages are represented
as azimuthal lines ending with a circle at the energy level of the average.
I.T. Arkin / Biochimica et Biophysica Acta 1565 (2002) 347–363354
through interactions of its transmembrane a-helix. Amaz-
ingly though, despite all of the scientific interest that it has
sparked as a model system, glycophorin A still lacks an
identifiable function. Below I describe the structure of the
dimeric complex of the transmembrane domain of glyco-
phorin A.
In a landmark study, MacKenzie et al. [63] employed
solution NMR to study the structure of a peptide corre-
sponding to residues 62–101 of glycophorin A, which
encompasses the transmembrane domain, in dodecylphos-
phocholine micelles at 40 jC. The structure was solved
using side-chain dihedral angle restraints from quantitative J
couplings and NOE-based distance restraints. Since glyco-
phorin A is a homo-dimer, difficulty arises when trying to
differentiate between inter- and intra-helical distance
restraints. Only six distance restraints could not have been
accounted for by constructing a monomeric structure, and
were therefore treated as exclusively intermolecular distance
restraints (see Table 1). For all other NOEs, the authors have
ingeniously ‘‘allowed’’ every distance restraint to be either
intermolecular or intramolecular due to the ambiguity of the
data. No explicit symmetry constraints were employed
during the solution phase. Symmetry, however, was inherent
in the system since each monomer contributed exactly the
same signals and resulting constraints. On average, the
NMR studies yielded eight experimental restraints per
residue in the transmembrane region.
Using a novel method based on site-specific FTIR
dichroism, Arkin et al. [68] analyzed the structure of
isotopically labeled glycophorin A transmembrane peptide
Table 1
Unambiguous intermolecular NOE distance restraints derived from solution
NMR 3D NOESY-HSQC spectra of the dimerizing glycophorin A
transmembrane domains in dodecylphosphocholine micelles [63]
Helix 1 Helix 2 Distance (A˚)
V80 Hg2 G79 HN 2.0–3.5
L75 Hy1 I76 Hh 2.6–3.8
V84 Hg2 T87 Hg1 1.9–2.8
V84 Hg2 G83 Ha 2.1–3.0
T87 Hg2 I88 Hg1 2.1–3.0
V84 Ha T87 Hg1 2.1–3.0
Fig. 4. Energy surface diagram of transmembrane helix–helix interactions for the dimeric human glycophorin A transmembrane domain as a function of the
helix tilt, b and the rotational pitch angle /. The color index corresponds to energy in units of kilocalories per mole.
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dimers in lipid (1,2-dimyristoyl-sn-glycero-3-phosphocho-
line) bilayers at room temperature. The structural parameters
obtained from the aforementioned method include the helix
tilt, b and the rotational position of the labeled residue about
the helix axis (see Fig. 2). The results obtained are indis-
tinguishable from those obtained from the NMR analysis in
dodecylphosphocholine micelles.
The structure obtained for glycophorin A by solution
NMR is that of a right-handed helical bundle with an inter-
helix crossing angle of X = 40j, as shown in Fig. 5.
Contrary to the coiled coils that one observes in left-handed
helical bundles, a right-handed bundle can form from
straight helices, in which the contacts between the helices
occur every 3.9 residues. This contact periodicity, and the
subsequent assumption that glycophorin A forms right-
handed dimers, was identified early on in mutagenesis
studies of glycophorin A [40], whereby the residues that
were found sensitive toward substitution exhibited the
aforementioned periodicity.
The formation of a bundle from straight helices in which
the crossing angle is X = 40j results in the fact that the
contact area between the two helices is relatively small, 400
A˚2. The structure entails seven residues that make favorable
inter-helix van der Waals contacts. These are the exact same
residues shown by saturating mutagenesis in SDS-PAGE
[40] to be sensitive toward substitution when assaying for
dimerization (see Figs. 6 and 7). The contact between the
two helices is very tight and the inter-helical separation is
7.0 A˚.
As pointed out by MacKenzie et al. [63], close inspec-
tion of the structure reveals several interesting features. The
side-chain rotamer angles are practically ideal, as expected.
Out of the seven residues that are responsible for the
intermolecular contacts (see Fig. 6), two are glycines and
four are h-branched (Val and Ile) and can have only one v1
rotamer in an a-helix [46]. Therefore, the contact surfaces
of the glycophorin A helix is preformed and does not
significantly change upon dimerization. In other words,
there is little, if any loss of conformational entropy upon
oligomerization.
Another interesting feature of the dimer structure is that
the governing interaction stabilizing the structure is van der
Walls contacts between apolar side chains. The only prob-
able intermolecular polar interactions are those of Thr87
OUH: : :O [80] and the CaUH: : :O hydrogen bonds [51]
mentioned above. Higher resolution structures will aid in the
confirmation of these interactions.
2.1.1. Solid-state NMR studies of glycophorin A in frozen
membranes
Glycophorin A has also been a target of structural
analysis by solid-state NMR undertaken by the Smith group
[81,80]. Site-specific isotopically labeled peptides encom-
passing the transmembrane domain are reconstituted in lipid
membranes, followed by freezing and magic-angle spinning
solid-state NMR analysis. The distances between the 13C
isotopic labels can then be determined by several magnet-
ization exchange techniques such as rotational resonance
[64]. Once again, experimental complications arise due to
the fact that glycophorin A is a homo-dimer. In this instance,
the authors used two different kinds of peptides, each
labeled in a different position, whereby the magnetization
Fig. 5. Helical diagrams of the transmembrane dimer of glycophorin A in dodecylphosphocholine micelles [63] in orthogonal views. Note the formation of a
right-handed contact between the virtually straight helices. Figure generated by molscript [79].
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is exchanged from one label to the other [64]. The peptides
were then mixed in such ratios, such that all labels that
‘‘donate’’ magnetization are under populated and are
assured to be near magnetization ‘‘acceptors’’.
The distance restrains are then employed as an energy
refinement terms in a molecular dynamics protocol aimed
at predicting the structure of the helical bundle, known as
global searching molecular dynamics [73] (see Section
1.6). Thus, it is imperative to understand that any struc-
tural details on non-labeled groups is purely a result of
the computational protocol used, due to chemical con-
straints and helical geometry. Table 2 lists the inter-helical
distance restraints generated by the aforementioned
method.
The structural model of Smith et al. [80] differs slightly
from the structure determined by MacKenzie et al. [63] in
solution, as shown in Fig. 7. The helices in the Smith model
are rotated about their axes by f 25j relative to the NMR
structure. Furthermore, the crossing angle between the
helices is reduced relative to the solution NMR structure
from 40j to 35j.
Smith et al. [80] point to several factors that might cause
the differences between their structure to that derived from
solution NMR. Namely, that the measurements are not
undertaken under the same conditions, alluding to the fact
that glycophorin A adopts a different structure in a lipid
bilayer versus a detergent micelle. It is difficult, however, to
reconcile these arguments with the site-specific FTIR
dichroism data undertaken in a lipid bilayer [68] which
yield exactly the same geometrical constants as the solution
NMR data. However, it is possible to delineate between the
solution NMR in detergents and the site-specific FTIR in
membrane studies, versus the solid-state NMR in membrane
study in that the first two measurements were undertaken at
room temperature or above, while the solid-state NMR data
are obtained at  10 jC.
The outcome of these differences is that in the Smith
model, the Gly residues forming the GxxxG motif (Gly79
and Gly83) are in contact with one another (see Fig. 7). In
other words, glycines 79 from each helix are in contact
with each other, as are glycines 83. Additionally, the
rotation enables Thr87 to hydrogen bond across the dimer
interface.
2.2. Influenza A M2 H+ channel
The M2 protein from Influenza A was the last step to be
elucidated in the life cycle of the Influenza virus [82]. Viral
attachment and entry is carried out through the activity of
Fig. 6. Helical diagrams of the transmembrane dimer of glycophorin A in
dodecylphosphocholine micelles [63], depicting the residues that make
intermolecular contacts. The legend on the right identifies the vertical
coloring of each residue. For clarity, residues of opposite molecules are
colored differently. Figure generated by molscript [79].
Table 2
Intermolecular distance restraints derived from solid-state NMR magic
angle spinning rotational resonance spectra of the dimerizing glycophorin A
transmembrane domains in frozen lipid bilayers
Helix 1 Helix 2 Distance (A˚)
G79 Ca G79 C 3.8–4.4
I76 C G79 Ca 4.5–5.1
G83 Ca G83 C 4.0–4.6
G83 Ca V80 C 3.9–4.5
G79 C V80 Cg 3.7–4.3
G83 C V84 Cg 3.7–4.3
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the major viral spike glycoprotein HA. Membrane fusion
and viral genome release occurs after HA undergoes a pH-
dependent irreversible conformational change in the acidic
endosome, but it was not clear at first why HA did not
change conformation in the Golgi secretory pathway where
the pH is lower than that of the cytosol. The answer to this
question came on identifying the pH-dependent ion channel
activity of M2, which negates the activity of the Golgi H+
ATPase [21].
M2 also participates in the virus uncoating process after
viral uptake by endocytosis. The passage of H+s from the
acidic environment of the endosomal lumen into the virion
lumen (through M2) weakens the interactions between the
matrix protein (M1) and the ribonucleoprotein (RNP) core,
enabling the release of the viral genome into the cytoplasm
[83].
The ion channel activity of M2 has been investigated
in some detail and has been shown to be blocked by
amantadine and BL-1743 which are both potent anti-
Influenza agents [84]. Amantadine-resistant strains of
Influenza exhibit mutations in the M2 proteins that render
them insensitive to amantadine ion channel blockage.
Fig. 7. Comparison between the solution NMR structure of glycophorin A in dodecylphosphocholine micelles [63] (right panel) and the solid-state NMR
structure [80] (left panel). Five slices are presented each with four amino acids, whereby the different residues are color coded. For clarity, identical residues in
different protomers are color coded differently according to the legend in the middle. Residues labeled in purple or red (e.g. L75 and G83) are those identified
by mutagenesis to be sensitive to dimer disruption in SDS-PAGE [40]. Residues labeled in red (e.g. G79) are those identified by mutagenesis to be sensitive to
dimer disruption in lipid bilayers [53]. Figure generated by molscript [79].
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Furthermore, the channel is activated by low pH, and the
His residues that reside in the transmembrane segment
have been shown to be essential for this function [85,86].
Interestingly, a homolog of M2 is not found in Influenza
B or Influenza C, both of which contain additional proteins
(NB and CM2, respectively) with similar structural and
functional characteristics, but no sequence similarity [87].
Much less is known about the CM2 protein of Influenza C
virus [88] and NB from Influenza B [89,90].
M2 was shown to be a homo-tetrameric membrane
protein, linked by disulfide bonds [84]. Mutation of the
cysteine residues does not affect the channel activity of the
protein and synthetic peptides corresponding to the trans-
membrane domain alone exhibit similar channel activity and
Fig. 8. Solid-state NMR structure of the transmembrane region of the Influenza A M2 H+ channel [67]. The upper panel depicts two orthogonal views of the
helical assembly including the His residue implicated in pH channel activation [85,86], whereas the bottom panel represents slices of space filling
representations of the channel. Figure generated by molscript [79].
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amantadine sensitivity [84]. Taken together, the data suggest
that tetramerization is initiated by the transmembrane
domain and subsequently stabilized by cytoplasmic disul-
fide bonds.
Both solid-state NMR [91,92] and site-specific FTIR
[69] studies of a transmembrane domain of M2 were able
to show that the transmembrane helices of M2 are tilted
from the membrane normal by about 30j–40j and that the
rotational pitch angle (see definition in Fig. 2) about the
helix axis of A29 is  60j. Wang et al. [67] have recently
reported a detailed solid-state NMR study of M2 in which
spatial restraints were gathered for every amino acid in the
transmembrane peptide. The spatial restraints resulted in a
promoter structure of M2 in which the helices are nearly
perfectly canonical and are tilted from the membrane normal
by 38j. Constructions of a tetrameric assembly from the
monomer structure by Wang et al. [67] resulted in the
structure shown in Fig. 8. The structure places the His
Fig. 9. Site-specific FTIR structure of the transmembrane region of phospholamban [75]. The upper panel depicts two orthogonal views of the helical assembly,
whereas the bottom panel represents slices of space filling representations of the channel. Figure generated by molscript [79].
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residues implicated in the pH activation of the channel [85]
in the bundle core. Furthermore, residues implicated in
binding the anti-Influenza A channel blocking drug aman-
tadine are located in the channel lumen as well.
2.3. Phospholamban
Phospholamban is a 52-amino-acid protein resident in the
cardiac sarcoplasmic reticulum (see Refs. [93–95] for
reviews). Its role is the regulation of the Ca2 + ATPase by
way of an inhibitory association. h-Adrenergic stimulated
phosphorylation of phospholamban relieves this inhibition,
enabling the Ca2 + pump to restore the Ca2 + gradient across
the sarcoplasmic reticulum faster, leading to a more rapid
heart rate.
Structurally, phospholamban is known to be a non-
covalent, homo-pentameric protein in which the pentame-
rization is driven solely by the transmembrane domains.
The pentamerization of phospholamban persists in SDS-
PAGE enabling mutagenesis analysis to outline which
residues are critical for pentamerization. Work by Arkin et
al. [60] was able to identify the following key residues as
being critical for pentamerization: LxxIxxxLxxI (Leu37–
Ile47). Model building efforts by the Engelman and Brunger
groups [60,73] using global searching molecular dynamics
simulation predicted a structure for the protein that was
consistent with the aforementioned mutagenesis data. How-
ever, work by Simmerman et al. [96] suggested an alter-
native structure of the pentameric complex that was
consistent with the mutagenesis data as well. Finally, Torres
et al. [75] employing site-specific FTIR data were able to
obtain a structural model of the transmembrane domain of
phospholamban that was consistent with the Simmerman
model [96]. This model of phospholamban is depicted in
Fig. 9.
One of the most interesting aspects of the model is that
structure of phospholamban is similar to the pentamerization
of the water-soluble COMP protein elucidated by Malash-
kevich et al. [97]. In fact, as stated in Section 1.2, Frank et
al. [27] were able to covert the pentamerization sequence of
phospholamban into a water-soluble protein similar to
COMP.
Another intriguing feature of the phospholamban sequence
are the three Cys residues interspersed amongst the Leu and
Ile residues. Mutagenesis studies [98] were able to show that
none of these Cys residues are essential for pentamerization,
nor for the function of the protein. However, while replace-
ment of any two cysteines did not result in pentamer dis-
ruption, replacement of all three residues did [98]. Their role
in the structure is not clear although FTIR analysis [99]
indicated that all three residues are hydrogen bonded to the
carbonyl residues at position i 4 in the sequence.
Finally, it is noteworthy that phospholamban transmem-
brane domain sequence does not end with any polar residue
aside from the terminal carboxyl. It is not clear if this has
anything to do with the protein’s function or rather with the
incorporation of the protein in the lipid bilayer as phospho-
lamban does not have a signal sequence.
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